Arvinas
Biopharmaceutical company developing targeted protein degradation therapeutics using proprietary PROTAC technology platform to treat cancer, neurological disorders, and other diseases by selectively degrading disease-causing proteins.
About
What Arvinas is
Biopharmaceutical company developing targeted protein degradation therapeutics using proprietary PROTAC technology platform to treat cancer, neurological disorders, and other diseases by selectively degrading disease-causing proteins.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://arvinas.com |
| Status coverage | Public status page |
| Founded | 2013 |
| Headquarters | New Haven, Connecticut, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...